Cardiac allograft rejection late after transplantation is a risk factor for graft coronary artery disease

Transplantation

Volumn 65, Issue 4, 1998, Pages 538-543

  Brunner La Rocca, Hans Peter ^a   Schneider, Jakob ^a   Künzli, Andreas ^a   Turina, Marko ^a   Kiowski, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BIOPSY, NEEDLE; CHILD; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032570745     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199802270-00015     Document Type: Article

References (62)

1. Gao SZ, Alderman EL, Schroeder JS, Silvennan JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 1988; 12: 334.
2. Uretsky BF, Murali S, Reddy PS, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987; 76: 827.
3. Miller LW, Schlant RC, Kobashigawa J, Kubo SH, Renlund DG. 24th Bethesda Conference: cardiac transplantation - Task Force 5: complications. J Am Coll Cardiol 1993; 22: 41.
4. Gao SZ, Schroeder JS, Alderman EL, et al. Prevalence of accelerated coronary artery disease in heart transplant survivors comparison of cyclosporine and azathioprine regimens. Circulation 1989; 80: III100.
5. St.Goar FG, Pinto FJ, Alderman EL, et al. Intracoronary ultrasound in cardiac transplant recipients: in vivo evidence of "angiographically silent" intimal thickening. Circulation 1992; 85: 979.
6. Rickenbacher PR, Pinto FJ, Chenzbraun A, et al. Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol 1995; 25: 171.
7. Billingham ME. Pathology and etiology of chronic rejection of the heart. Clin Transplant 1994; 8: 289.
8. Winters GL, Kendall TJ, Radio SJ, et al. Post-transplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts. J Heart Transplant 1990; 9: 364.
9. Escobar A, Ventura HO, Stapleton DD, et al. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and nonimmunologic risk factors. Am J Cardiol 1994; 74: 1042.
10. Eich D, Thompson JA, Ko DJ, et al. Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease. J Heart Lung Transplant 1991; 10: 45.
11. Mehra MR, Stapleton DD, Ventura HO, et al. Influence of donor and recipient gender on cardiac allograft vasculopathy: an intravascular ultrasound study. Circulation 1994; 90: 1178.
12. Sharples LD, Caine N, Mullins P, et al. Risk factor analysis for the major hazards following heart transplantation: rejection, infection, and coronary occlusive disease. Transplantation 1991; 52: 244.
13. Skowronski EW, Mendoza A, Smith SC Jr, Jaski BE. Detection of cytomegalovirus in paraffin-embedded postmortem coronary artery specimens of heart transplant recipients by the polymerase chain reaction: implications of cytomegalovirus association with graft atherosclerosis. J Heart Lung Transplant 1993; 12: 717.
14. Grattan MT, Moreno Cabrai CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
15. Barr ML, Cohen DJ, Benvenisty AI, et al. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts. Transplant Proc 1993; 25: 262.
16. Rose EA, Pepino P, Barr ML, et al. Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant 1992; 11: S120.
17. Suciu Foca N, Reed E, Marboe C, et al. The role of anti-HLA antibodies in heart transplantation. Transplantation 1991; 51: 716.
18. Smith JD, Danskine AJ, Rose ML, Yacoub MH. Specificity of lymphocytotoxic antibodies formed after cardiac transplantation and correlation with rejection episodes. Transplantation 1992; 53: 1358.
19. Rose EA, Smith CR, Petrossian GA, Barr ML, Reemtsma K. Humoral immune response after cardiac transplantation: correlation with fatal rejection and graft atherosclerosis. Surgery 1989; 106: 203.
20. Chow LH, Huh S, Jiang J, Zhong R, Pickering JG. Intimal thickening develops without humoral immunity in a mouse aortic allograft model of chronic vascular rejection. Circulation 1996; 94: 3079.
21. Hosenpud JD, Everett JP, Morris TE, Mauck KA, Shipley GD. Cardiac Allograft Vasculopathy: association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation 1995; 92: 205.
22. McAllister HA, Jr. Histologic grading of cardiac allograft rejection: a quantitative approach. J Heart Lung Transplant 1990; 9: 277.
23. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group - The International Society for Heart Transplantation. J Heart Transplant 1990; 9: 587.
24. Billingham ME. The pathology of transplanted hearts. Semin Thorac Cardiovasc Surg 1990; 2: 233.
25. Hess ML, Hastillo A, Mohanakumar T, et al. Accelerated atherosclerosis in cardiac transplantation: role of cytotoxic B-cell antibodies and hyperlipidemia. Circulation 1983; 68: II-94.
26. Hammond EH, Yowell RL, Price GD, et al. Vascular rejection and its relationship to allograft coronary artery disease. J Heart Lung Transplant 1992; 11: S111.
27. Russell PS, Chase CM, Winn HJ, Colvin RB. Coronary atherosclerosis in transplanted mouse hearts. II. Importance of humoral immunity. J Immunol 1994; 152: 5135.
28. Clausell N, Molossi S, Sett S, Rabinovitch M. In vivo blockade of tumor necrosis factor-a in cholesterol-fed rabbits after cardiac transplantation inhibits acute coronary artery neointimal formation. Circulation 1994; 89: 2768.
29. Russell ME, Hancock WW, Akalin E, et al. Chronic cardiac rejection in the LEW toF344 rat model: blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest 1996; 97: 833.
30. Shi C, Lee WS, He Q, et al. Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci USA 1996; 93: 4051.
31. Kobashigawa J, Kirklin JK, Naftel DC, et al. Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1993; 12: 355.
32. Kirklin JK, Naftel DC, Bourge RC, et al. Rejection after cardiac transplantation: a time-related risk factor analysis. Circulation 1992; 86: II236.
33. Kubo SH, Naftel DC, Mills RM, et al. Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. J Heart Lung Transplant 1995; 14: 409.
34. Brunner-La Rocca HP, Sütsch G, Schneider J, Follath F, Kiowski W. Natural course of moderate cardiac allograft rejection (International Society for Heart Transplantation grade 2) early and late after transplantation. Circulation 1996; 94: 1334.
35. Sethi GK, Rosado LJ, McCarthy M, Butman SS, Copeland JG. Futility of yearly heart biopsies in patients undergoing heart transplantation. J Thorac Cardiovasc Surg 1992; 104: 90.
36. Spratt P, Sivathasan C, Macdonald P, Keogh A, Chang V. Role of routine endomyocardial biopsy to monitor late rejection after heart transplantation. J Heart Lung Transplant 1991; 10: 912.
37. Koerner MM, Posival H, Minami K, et al. Heart transplantation at the Heart Center North Rhine-Westphalia. Clin Transpl 1992; 137.
38. Gallo P, Bardoldi G, Thiene G, et al. When and why do heart transplant recipients die? A 7 year experience of 1068 cardiac transplants. Virchows Arch A Pathol Anat Histopathol 1993; 422: 453.
39. Bolling SF, Putman JB, Abrams GD, McKay AM, Deeb GM. Hemodynamic versus biopsy findings during cardiac transplant rejection. Ann Thorac Surg 1991; 51: 52.
40. Winters GL, Costanzo Nordin MR, O'Sullivan EJ, et al. Predictors of late acute orthotopic heart transplant rejection. Circulation 1989; 80: III106.
41. Mehra MR, Ventura HO, Chambers R, et al. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study. J Am Coll Cardiol 1995; 26: 1537.
42. Johnson MR. Transplant coronary disease: nonimmunologic risk factors. J Heart Lung Transplant 1992; 11: S124.
43. Gao SZ, Hunt SA, Alderman EL, Hill IR, Yeung AC, Schroeder JS. Relationship of donor age and pre-existing coronary disease by angiography and intracoronary ultrasound to later development of cardiac allograft coronary artery disease [Abstract]. J Am Coll Cardiol 1995; 25: 158A.
44. Hosenpud JD, Novick RJ, Bennett LE, Keck BM, Fiol B, Daily OP. The Registry of the International Society for Heart and Lung Transplantation: thirteenth official report-1996. J Heart Lung Transplant 1996; 15: 655.
45. Handa N, Hatanaka M, Baumgartner WA, et al. Late cyclosporine treatment ameliorates established coronary graft disease in rat allografts. Transplantation 1993; 56: 535.
46. Epstein SE, Speir E, Zhou YF, Guetta E, Leon M, Finkel T. The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet 1996; 348 (suppl 1): s13.
47. Dummer S, Lee A, Breinig MK, Kormos R, Ho M, Griffith B. Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation. J Med Virol 1994; 44: 305.
48. Sorlie PD, Adam E, Melnick SL, et al. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study. J Med Virol 1994; 42: 33.
49. Span AH, Frederik PM, Grauls G, Van Boven GP, Bruggeman CA. CMV induced vascular injury: an electron-microscopic study in the rat. In Vivo 1993; 7: 567.
50. Zhou YF, Leon MB, Waclawiw MA, et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996; 335: 624.
51. Speir E, Huang ES, Modali R, et al. Interaction of human cytomegalovirus with p53: possible role in coronary restenosis. Scand J Infect Dis Suppl 1995; 99: 78.
52. Koskinen P, Lemstrom K, Bruggeman C, Lautenschlager I, Hayry P. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall: a possible linkage with enhanced allograft arteriosclerosis. Am J Pathol 1994; 144: 41.
53. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996; 335: 1792.
54. Singer DR, Jenkins GH. Hypertension in transplant recipients. J Hum Hypertens 1996; 10: 395.
55. Barbir M, Kushwaha S, Hunt B, et al. Lipoprotein(a) and accelerated coronary artery disease in cardiac transplant recipients. Lancet 1992; 340: 1500.
56. Meiser BM, Wenke K, Thiery J, et al. Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model. Transplant Proc 1993; 25: 2077.
57. Kobashigawa JA, Katznelson S, Laks H, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995; 333: 621.
58. Kottke TE, Weidman WE, Nguyen TT. Prevention of coronary artery disease. In: Giuliani ER, Gersh BJ, McGoon MD, Hayes DL, Schaff HV, eds. Mayo Clinic practice of cardiology. St. Louis: Mosby, 1996: 490.
59. Orchard TJ. The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Ann Med 1996; 28: 323.
60. Assmann G, Schulte H. Identification of individuals at high risk for myocardial infarction. Atherosclerosis 1994; 110 (suppl): S11.
61. Miller LW, Kubo SH, Young JB, Stevenson LW, Costanzo Nordin MR. Report of the consensus conference on candidate selection for heart transplantation: 1993. J Heart Lung Transplant 1995; 14: 562.
62. Brunner-La Rocca HP, Kiowski W. Identification of patients not requiring endomyocardial biopsies late after cardiac transplantation. Transplantation 1998; 65: 533.